ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 72 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | -100.0% | 41 | -92.3% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 530 | -27.6% | 0.00% | – |
Q2 2018 | $1,000 | – | 732 | +1162.1% | 0.00% | – |
Q1 2018 | $0 | – | 58 | -68.1% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 182 | -92.2% | 0.00% | – |
Q3 2017 | $8,000 | – | 2,336 | +4667.3% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 49 | -94.1% | 0.00% | – |
Q1 2017 | $3,000 | -57.1% | 828 | -43.5% | 0.00% | – |
Q4 2016 | $7,000 | – | 1,465 | +3473.2% | 0.00% | – |
Q3 2016 | $0 | – | 41 | -76.4% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 174 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 174 | -19.4% | 0.00% | – |
Q4 2015 | $1,000 | -75.0% | 216 | -79.8% | 0.00% | – |
Q3 2015 | $4,000 | +300.0% | 1,071 | +398.1% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 215 | -21.0% | 0.00% | – |
Q1 2015 | $1,000 | -50.0% | 272 | -51.7% | 0.00% | – |
Q4 2014 | $2,000 | – | 563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 5,292,156 | $7,144,000 | 0.82% |
Northeast Financial Consultants Inc | 732,265 | $988,000 | 0.30% |
Family Management Corp | 10,424 | $14,000 | 0.01% |
LMR Partners LLP | 81,550 | $110,000 | 0.01% |
ELEMENT CAPITAL MANAGEMENT LLC | 148,528 | $201,000 | 0.01% |
Poehling Capital Management, INC. | 3,302 | $4,000 | 0.00% |
Paloma Partners Management Co | 143,800 | $194,000 | 0.00% |
Founders Capital Management | 3,000 | $4,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 186,254 | $251,000 | 0.00% |
FNY Investment Advisers, LLC | 4,230 | $5,000 | 0.00% |